Transatlantic Medical Corp is looking to ramp up the production of its improved COVID-19 respirators. It...

  

Transcribed Image Text:

Transatlantic Medical Corp is looking to ramp up the production of its improved COVID-19 respirators. It expects this project to have the following incremental income statement and incremental pro-forma partial balance sheet: Fiscal Vear 2021 2020 2022 2023 Incr. Income Revenues 20.1 56.7 69.6 61.8 Costs 12.5 34.8 42.7 37.9 Assets Inventories 1.2 2.8 3.5 3.1 Acc Receivable 0.6 1.3 1.6 1.4 Liabilities Accounts Payable 1.2 2.0 2.5 2.2 *A figures are in milions of dolarn. The project will begin in 2020 with a capital expenditure of $16 million. Follow up capital expenditures of $2 million, $3 million, and $1 million are expected in 2021, 2022, and 2023 respectively. All capex is fully depreciable to zero book value over 4 years on a straight-line basis. The marginal tax rate for the project is 38.0%. What is the expected incremental cash flow in 2022 from the COVID-19 respirators project? million (Give answer to 2 decimal places) Transatlantic Medical Corp is looking to ramp up the production of its improved COVID-19 respirators. It expects this project to have the following incremental income statement and incremental pro-forma partial balance sheet: Fiscal Vear 2021 2020 2022 2023 Incr. Income Revenues 20.1 56.7 69.6 61.8 Costs 12.5 34.8 42.7 37.9 Assets Inventories 1.2 2.8 3.5 3.1 Acc Receivable 0.6 1.3 1.6 1.4 Liabilities Accounts Payable 1.2 2.0 2.5 2.2 *A figures are in milions of dolarn. The project will begin in 2020 with a capital expenditure of $16 million. Follow up capital expenditures of $2 million, $3 million, and $1 million are expected in 2021, 2022, and 2023 respectively. All capex is fully depreciable to zero book value over 4 years on a straight-line basis. The marginal tax rate for the project is 38.0%. What is the expected incremental cash flow in 2022 from the COVID-19 respirators project? million (Give answer to 2 decimal places)